Accelerant (ARX) Q3 2026 earnings review

Accelerant's marketplace fees climb, but higher insurance claims cut profit

Accelerant, an insurance marketplace connecting specialty agencies with insurers, grew its fee business while claims pushed its underwriting unit into a loss. Chief executive Jeff Radke said platform premiums rose 27% from a year ago to $1.33 billion as 26 new agencies joined. However, a higher claims ratio wiped out ceding commissions in the underwriting division, so profit per share excluding one-offs fell 25% to $0.18.

At a glance
Exchange Written Premium$1.33B +27% from a year ago
Operating revenue, excluding investment swings$280.2M +23% from a year ago
Profit per share, excluding one-offs$0.18 -25% from a year ago
Full-year outlookWithdrawn cancelled due to pending Thoma Bravo buyout

⚖️ Verdict: 🔴 Bearish

The story got worse because rising claims and negative internal accounting adjustments hit profits just as the pending Thoma Bravo buyout ended forward disclosures. On the positive side, outside insurers took 49% of platform premiums and existing-member retention rebounded to 116% after lapping a cancelled Canadian partner. One caution: thegross loss ratio jumped 6.7 percentage points to 56.8%, creating a $13.2 million underwriting Adjusted EBITDA loss.

The question now is whether the third-quarter claims jump is a one-quarter blip or worsening loss experience across policies ceded to partner insurers. One view is that fee income from the 49% outside-insurer share insulates Accelerant; the other is that rising claims will keep cutting ceding commissions until the buyout closes in the first half of 2027. The sliding-scale commission footnote in the upcoming third-quarter 10-Q filing will tell.

🐂 Bull Case

🟢🟢 strengthening GROWTH

Outside Insurers Now Write Almost Half the Volume

Accelerant runs a marketplace that connects specialty insurance agencies with insurance companies that take on the risk. The group wants outside insurers to write roughly two-thirds of its Exchange Written Premium, the total policies sold through its platform, over the next three to five years. Moving policies to outside partners generates fee income without tying up Accelerant's own balance sheet.

Outside insurers wrote 49% of total platform premiums this quarter, up from 47% last quarter and 32% a year ago. Because last quarter's jump included a one-time contract change, holding the 49% level shows real demand from partner insurers. Direct commission income from unaffiliated partners more than doubled from a year ago to $90.9 million, lifting Exchange Services revenue 32% to $112.6 million.

What to watch: the quarterly filing's breakdown of third-party premium by partner. Accelerant previously aimed to reduce its largest partner, Hadron, below one-third of outside volume by the fourth quarter, down from 34% in the second quarter.

🟢 fading PRODUCT

Existing Member Growth Stabilised as Volume Accelerated

Platform volume growth depends on signing up new managing general agents (MGAs), the specialized agencies that use Accelerant's software and data tools to write policies, and getting existing members to write more business. Over the past year, net revenue retention — the premium volume kept and expanded from existing members over twelve months — fell from 151% to 111%, raising concern that the core growth engine was slowing.

Both member additions and retention improved this quarter. Chief executive Jeff Radke said "We added 26 MGAs during the quarter, maintaining the upward momentum of our high-quality, specialty underwriting talent", lifting total members to 340. Net revenue retention rose to 116%, while total platform premium growth sped up to 27% from 23% last quarter as the company moved past last year's termination of a large Canadian agency.

What to watch: net revenue retention in the fourth-quarter report. Holding above 115% will confirm that existing agencies are still expanding their volume on the platform.

🐻 Bear Case

🔴🔴 strengthening MARGIN contradicts narrative

Underwriting Swung to a Loss as Claims Rose

Finance chief Linda S. Huber highlighted the fee divisions, noting "Our fee-based businesses, which we define as consolidated results less the Underwriting segment, delivered $84.5 million of adjusted EBITDA, representing growth of 75% year over year." That framing leaves out the Underwriting division, where Accelerant retains insurance risk on its own balance sheet and collects ceding commissions from reinsurers.

Higher claims pushed the Underwriting division into the red and dragged down total company margins, cutting against Huber's focus on fee growth. By the numbers:

  • Gross loss ratio (claims as a share of earned premiums): 56.8%, up 6.7 percentage points from a year ago
  • Underwriting ceding commission revenue: negative $2.2 million, down from positive $29.0 million a year ago
  • Losses and loss adjustment expenses: 25.2% of operating revenue, up 2.9 percentage points by our math
  • Underwriting Adjusted EBITDA (operating profit before interest, tax and depreciation, excluding one-offs): a loss of $13.2 million, compared with a $17.2 million profit a year ago

Because reinsurers pay sliding-scale commissions that shrink when claims rise, the jump in the loss ratio wiped out the segment's commission revenue and reduced total Adjusted EBITDA margin from 29% to 25%.

What to watch: the sliding-scale commission adjustment note in the third-quarter 10-Q filing. A larger downward adjustment than last quarter's $7.1 million would show worsening claims on policies ceded to reinsurers.

🔴 persistent DISCLOSURE

Internal Accounting Adjustments Hurt Profit This Quarter

Because Accelerant's agencies, marketplace and insurance companies do business with one another, management removes internal fees and timing differences in a consolidation and elimination line. Last quarter, that line unexpectedly added $7.5 million to Adjusted EBITDA, creating most of the company's profit beat.

This quarter, the elimination line swung back to a $10.2 million deduction, worse than the $3.9 million deduction a year ago. While combined segment Adjusted EBITDA rose 12% by our math to $101.6 million, the larger elimination drag held consolidated Adjusted EBITDA growth to 9% at $71.3 million. Profit excluding one-offs fell 21% to $38.2 million, or $0.18 per share, as Accelerant also retained 11% of exchange premiums on its own books, up from 7% a year ago.

What to watch: the intercompany elimination footnote in the quarterly filing. It will show how much of the $17.7 million quarterly swing came from timing differences between segments.

🔴 persistent GOVERNANCE

Risks this quarter didn't answer

Because Accelerant held no conference call and has not yet filed its full quarterly report, three standing concerns got no new disclosure in the earnings release.

  • Insurance regulatory approvals for the Thoma Bravo buyout: Radke said the group still expects a first-half 2027 close, but the release gave no update on specific state or international insurance regulator clearances.
  • Concentration and governance with Hadron: Hadron, an insurer also backed by Accelerant's controlling shareholder Altamont, accounted for 34% of outside premium in the second quarter; the third-quarter share will only appear in the 10-Q filing.
  • Reinsurance commutations and loss portfolio transfers: last quarter's results relied on taking back and re-ceding hundreds of millions in loss reserves, and the release does not state whether new reserve transfers occurred in the third quarter.

👓 Other Themes

new CAPITAL ALLOCATION

Pending Thoma Bravo Buyout Ends Outlook and Halts Buybacks

Accelerant signed an agreement in August to sell itself to private-equity firm Thoma Bravo in an all-cash deal closing in the first half of 2027. The company stated that "Accelerant will not provide guidance for the fourth quarter of 2026 or the full year of 2026 as a result of the pending transaction" and cancelled its earnings call. By our math, share buybacks dropped to $1.0 million this quarter from $66.0 million in the second quarter.

💲 Other KPIs

Operating cash flow (26Q3) $321.0 million
⇄ reversing

Operating cash flow turned positive in the third quarter, bringing nine-month cash from operations to $231.0 million after a $90.0 million outflow in the first half. By our math, the platform generated $321.0 million of operating cash and $305.1 million of free cash flow this quarter as earlier reinsurance trust transfers settled.

Reinsurance recoverables (26Q3) $3,111.7 million
⇗ accelerating

Total amounts owed to Accelerant by its reinsurers rose 36.7% from the end of 2025 by our math, outpacing the 3.5% rise in unearned premiums. Recoverables on unpaid claims climbed 28.1% to $2,155.5 million, while other reinsurance recoverables jumped 60.9% to $956.2 million as ceded claims and partner settlements grew.

Diluted share count (26Q3) 217.2 million
⇘ decelerating

Weighted-average diluted shares fell 1.1% from the second quarter's 219.7 million following earlier share buybacks, though the count remains up 5.4% from a year ago after the July 2025 initial public offering. Because the company posted a $9.2 million GAAP net loss, it excluded 28.7 million employee stock options and awards from the diluted count.

❓ Key Questions

Why did Underwriting ceding commissions turn negative in Q3?

Underwriting segment ceding commission income dropped to negative $2.2 million from $29.0 million a year ago while the gross loss ratio reached 56.8%. Investors need to know which insurance lines and policy years drove the higher claims and sliding-scale commission penalties.

Did Hadron's share of outside premium fall below one-third?

Before withdrawing its outlook, management targeted reducing related-party insurer Hadron below one-third of third-party direct written premium by the fourth quarter, down from 34% in the second quarter. The release omitted the third-quarter figure.

What caused the $17.7 million swing in intercompany eliminations?

Consolidation and elimination adjustments moved from adding $7.5 million to Adjusted EBITDA in the second quarter to subtracting $10.2 million in the third quarter. Without a call, the split between timing differences and recurring intercompany fee eliminations is unclear.

Which insurance regulators still need to approve the buyout?

Closing the Thoma Bravo acquisition in the first half of 2027 requires approvals from insurance regulators across multiple jurisdictions where Accelerant's underwriting entities operate. The release provided no checklist of filings submitted or approvals received.